Magnesium sulfate is one of the most commonly used medications in obstetrics and its use is often in high-risk, high-acuity patients. The Institute for Safe Medication Practices classifies magnesium sulfate as a high-alert medication which has potential to cause significant harm if used in error. The objective of this quality improvement study was to describe magnesium sulfate errors in our inpatient obstetrics unit. We performed a retrospective analysis of all medication errors involving magnesium sulfate from January 1, 2016 to December 31, 2018 using the institution’s centralized risk management event reporting system. Our multidisciplinary quality improvement team utilized process mapping to outline the workflow from medication ordering to administration for magnesium sulfate and then classified and superimposed all magnesium errors by process step onto our process map in order to identify areas to target for improvement. During the time analyzed there were twenty-eight magnesium errors reported. Errors occurred most frequently during medication administration (n=17). The wrong infusion rate was the most frequent administration error (n=7), with 3 of these errors leading to harm (Figure 1). Figure 2 depicts the process map generated by our team. The green circles indicate the number of errors occurring at that specific process step. This study demonstrates how a multidisciplinary quality improvement process can be utilized to address medication errors on labor & delivery units. We identified administration errors, specifically wrong infusion rate, as a significant portion of magnesium errors at our institution with real potential to cause harm. This information has helped our team develop a new protocol for magnesium administration with safeguards built in to prevent these types of errors from occurring. We will be tracking post protocol implementation error rates to determine the success of these changes.View Large Image Figure ViewerDownload Hi-res image Download (PPT)